SETD2 and cancer: We identified hypoxia-inducible factor 1 (HIF 1) pathway, blood vessel development (15), adipocyte regulation, retinoic acid regulation, hypoxic signaling, associated cytokine pathways (54), PI3/Akt signaling, and pathways in cancer (55) as pathways that are potentially contributory.